Krieger CC - Search Results

1

Exon-skipped dystrophins for treatment of Duchenne muscular dystrophy: mass spectrometry mapping of most exons and cooperative domain designs based on single molecule mechanics.

Krieger CC, Bhasin N, Tewari M, Brown AE, Safer D, Sweeney HL, Discher DE. Krieger CC, et al. Cytoskeleton (Hoboken). 2010 Dec;67(12):796-807. doi: 10.1002/cm.20489. Epub 2010 Nov 10. Cytoskeleton (Hoboken). 2010. PMID: 20886611 Free PMC article.

2

Cysteine shotgun-mass spectrometry (CS-MS) reveals dynamic sequence of protein structure changes within mutant and stressed cells.

Krieger CC, An X, Tang HY, Mohandas N, Speicher DW, Discher DE. Krieger CC, et al. Proc Natl Acad Sci U S A. 2011 May 17;108(20):8269-74. doi: 10.1073/pnas.1018887108. Epub 2011 Apr 28. Proc Natl Acad Sci U S A. 2011. PMID: 21527722 Free PMC article.

3

Heart-specific stiffening in early embryos parallels matrix and myosin expression to optimize beating.

Majkut S, Idema T, Swift J, Krieger C, Liu A, Discher DE. Majkut S, et al. Curr Biol. 2013 Dec 2;23(23):2434-9. doi: 10.1016/j.cub.2013.10.057. Epub 2013 Nov 21. Curr Biol. 2013. PMID: 24268417 Free PMC article.

4

The Adverse Effects Profile of Teprotumumab.

Stan MN, Krieger CC. Stan MN, et al. Among authors: krieger cc. J Clin Endocrinol Metab. 2023 Aug 18;108(9):e654-e662. doi: 10.1210/clinem/dgad213. J Clin Endocrinol Metab. 2023. PMID: 37071658 Free PMC article. Review.

5

Proximity ligation assay to study TSH receptor homodimerization and crosstalk with IGF-1 receptors in human thyroid cells.

Krieger CC, Boutin A, Neumann S, Gershengorn MC. Krieger CC, et al. Front Endocrinol (Lausanne). 2022 Sep 29;13:989626. doi: 10.3389/fendo.2022.989626. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36246873 Free PMC article.

6

Inhibition of TSH/IGF-1 Receptor Crosstalk by Teprotumumab as a Treatment Modality of Thyroid Eye Disease.

Krieger CC, Sui X, Kahaly GJ, Neumann S, Gershengorn MC. Krieger CC, et al. J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1653-e1660. doi: 10.1210/clinem/dgab824. J Clin Endocrinol Metab. 2022. PMID: 34788857 Free PMC article.

7

Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays.

Krieger CC, Kahaly GJ, Azam A, Klubo-Gwiezdzinska J, Neumann S, Gershengorn MC. Krieger CC, et al. Thyroid. 2022 Jan;32(1):90-96. doi: 10.1089/thy.2021.0326. Epub 2021 Nov 29. Thyroid. 2022. PMID: 34714162 Free PMC article.

8

The Forks in the Road of Thyroid Eye Disease.

Krieger CC. Krieger CC. J Clin Endocrinol Metab. 2021 Nov 19;106(12):e5262-e5263. doi: 10.1210/clinem/dgab500. J Clin Endocrinol Metab. 2021. PMID: 34232313 No abstract available.

9

Targeting TSH and IGF-1 Receptors to Treat Thyroid Eye Disease.

Neumann S, Krieger CC, Gershengorn MC. Neumann S, et al. Among authors: krieger cc. Eur Thyroid J. 2020 Dec;9(Suppl 1):59-65. doi: 10.1159/000511538. Epub 2020 Nov 2. Eur Thyroid J. 2020. PMID: 33511086 Free PMC article.

10

Is There Evidence for IGF1R-Stimulating Abs in Graves' Orbitopathy Pathogenesis?

Krieger CC, Neumann S, Gershengorn MC. Krieger CC, et al. Int J Mol Sci. 2020 Sep 8;21(18):6561. doi: 10.3390/ijms21186561. Int J Mol Sci. 2020. PMID: 32911689 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page